Swedish Biomimetics 3000 Ltd. (SB 3000) has developed μLOT, a new approach to manufacturing therapeutic peptides, which promises to replace traditional large scale batch manufacturing. The µLOT technology platform provides continuous manufacturing of peptides, enabling in-line process analytical technologies (PAT) throughout the process providing quality and control, as well as reduction in cost of goods, according to the company.   Peptide based medicines are widely used across many therapeut...